To elucidate how PRMT6 enhances the invasion of glioblastoma cells, we first analyzed the previously completed proteomic data [19] and found that the protein level of EZH2 was significantly down-regulated in PRMT6-deficient U87 cells. The gene discussed is EZH2; the disease is glioblastoma.